MedPath

The effect of probiotics on CF

Phase 3
Conditions
Cystic Fibrosis.
Cystic fibrosis
Registration Number
IRCT20181020041387N1
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Patients who have been diagnosed with CF based on clinical signs and sweat Chloride test.
No pulmonary exacerbation two weeks prior the study.
Ability to perform spirometry test.
The informed willingness to participate in the study.
Presence of no other chronic disorder except complications related to CF
Six to Twenty years old patients with Cystic Fibrosis disease.
The Forced Expiratory Volume in 1 second (FEV1) greater than 40%.
Stable clinical condition and no acute upper and lower respiratory infection.

Exclusion Criteria

Diagnosed as CF less than 6 months.
New complication of CF during the past 3 months.
No routine follow up.
Disability to perform and repeat spirometry test according to American Thoracic Society criteria

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath